Product correctly added to cart.

BMS-906024

CAS 1401066-79-2: BMS-906024

Description:BMS-906024, with the CAS number 1401066-79-2, is a small molecule inhibitor primarily known for its role in targeting the protein kinase activity of the enzyme CSF1R (colony-stimulating factor 1 receptor). This compound has garnered attention in the field of cancer research, particularly for its potential therapeutic applications in treating various malignancies by modulating the tumor microenvironment and inhibiting tumor-associated macrophages. BMS-906024 exhibits selective inhibition, which is crucial for minimizing off-target effects and enhancing its efficacy in clinical settings. The compound is typically characterized by its molecular structure, which includes specific functional groups that contribute to its biological activity. Additionally, it has been studied in preclinical models to evaluate its pharmacokinetics, safety profile, and overall effectiveness. As research continues, BMS-906024 may provide insights into novel treatment strategies for cancers that are resistant to conventional therapies.

Formula:C26H26F6N4O3

InChI:InChI=1S/C26H26F6N4O3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,22H,11-14H2,1H3,(H2,33,37)(H,35,38)/t16-,17+,22+/m0/s1

InChI key:InChIKey=AYOUDDAETNMCBW-GSHUGGBRSA-N

SMILES:O=C(N)C(CCC(F)(F)F)C(C(=O)NC1N=C(C=2C=CC=CC2)C=3C=CC=CC3N(C1=O)C)CCC(F)(F)F

Sort by


See more categories

This search does not contain any category.

Found 2 products.

discount label

BMS-906024

CAS:1401066-79-2

Ref: TM-T14680

1mg537.00 €
2mg748.00 €
5mg1,121.00 €
10mg1,700.00 €
25mg2,547.00 €
50mg3,440.00 €
100mg4,636.00 €
Estimated delivery in United States, on Thursday 20 Mar 2025
discount label

BMS 906024

Controlled Product
CAS:1401066-79-2

Ref: 3D-BB162475

Undefined sizeTo inquire
Estimated delivery in United States, on Tuesday 1 Apr 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".